Riskpilot← Back to searchSign inGet full accessEPION AS
ASActiveOrg 914834724Gamle E6 1302, 7620 SkognWholesale of pharmaceutical and medical goods · NACE 4646Est. 201510 employees
Revenue 2024
NOK 43,4M
+30% vs 2023
EBITDA margin
10.2%
+54% vs 2023
Equity ratio
55.1%
Financial strength
Net profit 2024
NOK 3M
+56% vs 2023
| Revenue | NOK 43,4M | +30% |
| EBITDA | NOK 4,4M | +54% |
| Net profit | NOK 3M | +56% |
| Total assets | NOK 14,7M | +40% |
| Equity | NOK 8,1M | +51% |
| Employees | 10 | — |
Legal name
EPION AS
Org number
914834724
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
27. januar 2015
Share capital
NOK 1 563 516
Employees
10 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Salg av handelsvarer og tjenester tilknyttet dette, forvaltning av fast eiendom, løsøre og verdipapirer, samt ved aksjer og parter å delta i andre selskaper og virksomheter.
Address
Gamle E6 1302, 7620 Skogn
Phone
+4791780354
Email
info@epion.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 54 | 358 | 2 542 | 8 471 | 11 298 | 13 720 | 19 051 | 33 486 | 43 415 |
| Staff expenses | −7 | −0 | −422 | −1 238 | −1 739 | −1 785 | −2 951 | −3 396 | −4 087 | −5 149 |
| EBITDA | −47 | 15 | −824 | −1 628 | −70 | 915 | 93 | 682 | 2 893 | 4 442 |
| Depreciation & amort. | −0 | −3 | −31 | −49 | −148 | −209 | −221 | −161 | −233 | −421 |
| EBIT | −47 | 13 | −855 | −1 677 | −218 | 707 | −128 | 520 | 2 661 | 4 021 |
| Net financials | 1 | −2 | −8 | −64 | −126 | −151 | −70 | −104 | −122 | −116 |
| Profit before tax | −47 | 10 | −863 | −1 741 | −344 | 556 | −197 | 416 | 2 539 | 3 905 |
| Tax | −12 | 3 | −198 | −373 | −74 | 123 | −42 | 94 | 595 | 878 |
| Net profit | −35 | 7 | −665 | −1 368 | −270 | 433 | −155 | 322 | 1 944 | 3 027 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 654 | 584 | 2 321 | 3 185 | 3 402 | 6 929 | 7 439 | 8 014 | 10 539 | 14 739 |
| Equity | 557 | 564 | 564 | 97 | −173 | 3 287 | 3 132 | 3 453 | 5 397 | 8 124 |
| Long-term debt | 0 | 0 | 1 200 | 2 425 | 2 275 | 2 275 | 2 097 | 1 879 | 1 622 | 1 385 |
| Short-term debt | 97 | 20 | 557 | 663 | 1 299 | 1 367 | 2 210 | 2 681 | 3 519 | 5 230 |
| Total debt | 97 | 20 | 1 757 | 3 088 | 3 574 | 3 642 | 4 307 | 4 560 | 5 141 | 6 615 |
EBITDA margin
10.2%
This company
15.8%
Market median
-35% vs market
20152024
Equity ratio
55.1%
This company
38.2%
Market median
+44% vs market
20152024
Return on equity
37.3%
This company
18.4%
Market median
+103% vs market
20152024
Net profit margin
7.0%
This company
8.1%
Market median
-14% vs market
20152024
Asset turnover
2.95×
This company
1.12×
Market median
+163% vs market
20152024
Debt / equity
0.81×
This company
0.62×
Market median
+31% vs market
20152024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
VS Chief Executive Officer | Chief Executive Officer | 2015 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Deinde As | Company | 18.8% | 18.8% | 2024 |
Jeca Invest As | Company | 17.5% | 17.5% | 2022 |
Rune Søberg As | Company | 14.8% | 14.8% | 2024 |
Viske As | Company | 14.0% | 14.0% | 2024 |
Winn As | Company | 14.0% | 14.0% | 2024 |
Tommy Aune Rehn As | Company | 13.3% | 13.3% | 2024 |
Morten Paulsen As | Company | 13.3% | 13.3% | 2024 |
André Vevle As | Company | 11.8% | 11.8% | 2024 |
Expo-Nor As | Company | 9.5% | 9.5% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Morten Paulsen As
EPION AS Board members of EPION AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Vegar Skreden | Chief Executive Officer | 0 companies |
| Rune Søberg | Board of Directors | 0 companies |
| Cato Sundal | Board of Directors | 0 companies |
| Morten Paulsen | Board of Directors | 0 companies |
| Erik Helmut Winn | Chairman | 0 companies |